June 2018, AxxessBio and BioScenergy entered into an exclusive distribution agreement for BioScenergy’s Valens Metabolics range of products in selected countries in Asia.
These products are for Inborn Errors of Metabolism (IEM) which are rare genetic disorders characterised by abnormal chemical reactions in the body disrupting the normal food metabolism.
BioScenergy is based in Kuala Lumpur, Malaysia. It specialises in medical nutrition, niche products and compounded medicines that are modular, halal certified and suited to Asian patients’ needs.
For more information on BioScenergy and its Valens Metabolics products, please visit www.bioscenergy.com
